Germany's Celesio Ordered to Sell Pharmacies for Sainsbury Deal Approval
July 29 2016 - 3:25AM
Dow Jones News
By Ian Walker
LONDON--The U.K. Competition and Markets Authority confirmed
Friday that Germany's Celesio AG (CLS1.XE) will have to sell
pharmacies in 12 areas of England and Wales to a new owner approved
by the regulator for its takeover of Sainsbury PLC's (SBRY.LN)
pharmacy business to get the green light.
The decision follows the regulator's initial review in April
which identified 13 areas where the two companies' pharmacies are
such close competitors that the merger would lead to a substantial
drop in competition. It added Friday that Celesio can't close the
pharmacies.
"By selling the Lloyds pharmacy in those areas to a new owner
with the relevant expertise and the incentive to attract customers
through its service quality, we can ensure that customers do not
lose out from this deal," said Simon Polito, inquiry chair.
The U.K.'s second-largest grocer by market share announced in
July 2015 that it was selling its pharmacy business to
LloydsPharmacy owner Celesio.
Celesio is buying Sainsbury's 277 pharmacies, which are usually
located inside Sainsbury's supermarkets. Through its LloydsPharmacy
subsidiary, Celesio operates around 1,540 pharmacies across the
U.K.
-Write to Ian Walker at ian.walker@wsj.com; @IanWalk40289749
(END) Dow Jones Newswires
July 29, 2016 03:10 ET (07:10 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Sainsbury (j) (LSE:SBRY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sainsbury (j) (LSE:SBRY)
Historical Stock Chart
From Apr 2023 to Apr 2024